Setting new standards in information exchange for the pharmaceutical and biotech industry
GDPR Impact on Medical Apps session confirmed for this Week’s London Meeting
May 9, 2018
Analogical, digital, device and sensor data linked to a living natural person is in scope of the EU’s new privacy framework, the GDPR. When such data is also biometric, genetic or carries information about someone’s health, it attracts an even higher protection. Medical and scientific research benefits from certain exemptions, but knowing which ones apply and how to design and use medical apps and connected devices lawfully is absolutely non-negotiable for the clinical deployment of digital biomarkers and innovation digital health-care.
Get the latest updates from GDPR analyst, Chiara Rustici at Mobile in Clinical Trials Europe, May 15-16, 2018 in London. For more information visit: www.theconferenceforum.org/conferences/mobile-clinical-trials-europe/overview.